Literature DB >> 29269943

Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease.

Robert N Schuck1, Michael Pacanowski1, Janet Woodcock2, Issam Zineh1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29269943     DOI： 10.1038/nrd.2017.231

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Next-generation medicines: past regulatory experience and considerations for the future.

Authors:  M A Pacanowski; C Leptak; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2014-03       Impact factor: 6.875

Review 2.  Patient-centric trials for therapeutic development in precision oncology.

Authors:  Andrew V Biankin; Steven Piantadosi; Simon J Hollingsworth
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

3.  The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.

Authors:  Anthony G Durmowicz; Robert Lim; Hobart Rogers; Curtis J Rosebraugh; Badrul A Chowdhury
Journal:  Ann Am Thorac Soc       Date:  2018-01
  3 in total
  2 in total

Review 1.  Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Authors:  Robert N Schuck; Janet Woodcock; Issam Zineh; Peter Stein; Jonathan Jarow; Robert Temple; Thomas Permutt; Lisa LaVange; Julia A Beaver; Rosane Charlab; Gideon M Blumenthal; Sarah E Dorff; Christopher Leptak; Steven Lemery; Hobart Rogers; Badrul Chowdhury; E David Litwack; Michael Pacanowski
Journal:  Clin Pharmacol Ther       Date:  2018-02-23       Impact factor: 6.875

2.  Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers.

Authors:  H Kim Lyerly; Jun Ren; Renzo Canetta; Gi Hyun Kim; Sumimasa Nagai; Tomohiro Yamaguchi; Ken Hatogai; Hiroshi Katayama; Silvy Da Rocha Dias; Daniel McManus; Kathy Soltys; Zhimin Yang; Olufumilayo Olopade; Nancy Goodman; Greg Reaman; Thomas Gross
Journal:  J Glob Oncol       Date:  2018-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.